SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-213432
Filing Date
2023-08-15
Accepted
2023-08-15 16:02:55
Documents
1
Group Members
ALBERT CHADANIEL ESTESFHMLS X, L.L.C.FHMLS X, L.P.FHMLS XI, L.L.C.FHMLS XI, L.P.FHMLSP OVERAGE, L.L.C.FHMLSP OVERAGE, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.FRAZIER LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.FRAZIER LIFE SCIENCES

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d536712dsc13da.htm SC 13D/A 351475
  Complete submission text file 0001193125-23-213432.txt   353710
Mailing Address 601 UNION STREET, SUITE 3200 TWO UNION SQUARE SEATTLE WA 98101
Business Address 601 UNION STREET, SUITE 3200 TWO UNION SQUARE SEATTLE WA 98101 (206) 621-7200
Frazier Life Sciences X, L.P. (Filed by) CIK: 0001790879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93833 | Film No.: 231174834
SIC: 2834 Pharmaceutical Preparations